AVO vs IVPR
Mission Produce, Inc. and Inspire Veterinary Partners, Inc., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | AVO | IVPR |
|---|---|---|
| Revenue | $1.4B | $16.6M |
| Net income | $37.7M | $-14.3M |
| Gross margin | 11.6% | · |
| Net margin | 2.9% | −86.0% |
| Return on equity | 6.6% | · |
| Diluted EPS | $0.53 | · |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $37.2M | $-10.2M |
| Equity | $587.3M | $1.6M |
| Net debt / equity | 0.05× | 7.34× |
| Current ratio | 1.95× | 0.25× |
| Revenue CAGR 5y | 10.0% | · |
| Profit CAGR 5y | 5.5% | · |
AVO bills 83.8× the revenue of IVPR, and IVPR closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
3 years side by side
| Fiscal year | AVO | IVPR |
|---|---|---|
| FY2024 | $1.2B | $16.6M |
| FY2023 | $953.9M | $16.7M |
| FY2022 | $1.0B | $9.8M |
Bottom line
| Fiscal year | AVO | IVPR |
|---|---|---|
| FY2024 | $36.7M | $-14.3M |
| FY2023 | $-2.8M | $-14.8M |
| FY2022 | $-34.6M | $-4.9M |
Standard deviation, each side
IVPR's net margin has been more volatile than AVO's over the 3 comparable fiscal years — 17.7 percentage points of standard deviation against 2.7.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.
Year by year
AVO led in net margin in every one of the 3 comparable fiscal years — a structural lead, not a recent swing.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.